Company logo

BIOL - BIOLASE, Inc.

NASDAQ -> Healthcare -> Medical Devices
Foothill Ranch, United States
Type: Equity

BIOL price evolution
BIOL
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 1 May 2023
Current assets
Cash $6.57 $7.81 $6.93 $6.53
Short term investments
Net receivables $5.48 $4.39 $5.72 $5.16
Inventory $11.43 $13.82 $13.33 $17.77
Total current assets $24.86 $27.78 $28.15 $31.96
Long term investments
Property, plant & equipment $7.04 $7.77 $8.28 $6.8
Goodwill & intangible assets $2.93 $2.93 $2.93 $2.93
Total noncurrent assets $10.24 $10.96 $11.49 $9.98
Total investments
Total assets $35.1 $38.74 $39.63 $41.94
Current liabilities
Accounts payable $6.07 $7.18 $6.31 $7.54
Deferred revenue $2.71 $2.43 $2.55 $2.44
Short long term debt $2.27 $2.8 $2.1 $1.4
Total current liabilities $19.66 $19.78 $18.38 $19
Long term debt $12.55 $12.3 $13.12 $13.93
Total noncurrent liabilities $13.48 $13.08 $13.91 $14.79
Total debt $14.82 $15.1 $15.22 $15.33
Total liabilities $33.15 $32.86 $32.29 $33.79
Shareholders' equity
Retained earnings -$316.8 -$311.47 -$306.88 -$302.02
Other shareholder equity -$0.55 -$0.72 -$0.61 -$0.65
Total shareholder equity -$0.25 $0.33 $6.62 $8.16
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $6.57 $4.18 $30.18 $17.88
Short term investments
Net receivables $5.48 $5.84 $4.24 $3.06
Inventory $11.43 $15.88 $12.93 $11.16
Total current assets $24.86 $28.96 $49.35 $35.11
Long term investments
Property, plant & equipment $7.04 $6.05 $2.78 $2.76
Goodwill & intangible assets $2.93 $2.93 $2.93 $2.93
Total noncurrent assets $10.24 $9.23 $5.93 $5.92
Total investments
Total assets $35.1 $38.19 $55.28 $41.02
Current liabilities
Accounts payable $6.07 $5.79 $3.31 $2.65
Deferred revenue $2.71 $2.53 $2.59 $2.28
Short long term debt $2.27 $0.7
Total current liabilities $19.66 $17.81 $13.84 $11.22
Long term debt $12.55 $13.09 $15.05 $17.96
Total noncurrent liabilities $13.48 $15.49 $16.23 $19.77
Total debt $14.82 $15.05 $15.05 $17.96
Total liabilities $33.15 $33.3 $30.08 $31
Shareholders' equity
Retained earnings -$316.8 -$296.17 -$267.53 -$251.38
Other shareholder equity -$0.55 -$0.73 -$0.62 -$0.39
Total shareholder equity -$0.25 $4.89 $25.21 $10.03
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 1 May 2023
Revenue
Total revenue $13.49 $10.92 $14.29
Cost of revenue $9.97 $7.17 $8.17
Gross Profit $3.52 $3.75 $6.12
Operating activities
Research & development $1.65 $1.36 $1.44
Selling, general & administrative $6.95 $6.08 $8.55
Total operating expenses $8.6 $7.44 $9.99
Operating income -$5.08 -$3.7 -$3.87
Income from continuing operations
EBIT -$4.74 -$3.98 -$4.25
Income tax expense -$0.01 $0.01 $0.03
Interest expense $0.6 $0.6 $0.58
Net income
Net income -$5.33 -$4.59 -$4.87
Income (for common shares) -$22.31 -$4.59 -$4.87
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $49.16 $48.46 $39.19 $22.78
Cost of revenue $32.44 $32.55 $22.66 $16.61
Gross Profit $16.72 $15.91 $16.53 $6.17
Operating activities
Research & development $6 $7.26 $6.05 $3.69
Selling, general & administrative $28.66 $33.98 $26.6 $21.01
Total operating expenses $34.66 $41.25 $32.96 $24.71
Operating income -$17.94 -$25.34 -$16.43 -$18.54
Income from continuing operations
EBIT -$18.24 -$25.78 -$13.87 -$14.34
Income tax expense $0.03 $0.11 $0.07 $0.13
Interest expense $2.36 $2.75 $2.22 $2.36
Net income
Net income -$20.63 -$28.63 -$16.16 -$16.83
Income (for common shares) -$37.62 -$28.85 -$16.16 -$16.83
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$5.33 -$4.59 -$4.87 -$5.85
Operating activities
Depreciation $0.67 $0.56 $1.42 $0.15
Business acquisitions & disposals
Stock-based compensation $0.18 $0.28 $0.08 $0.69
Total cash flows from operations -$2.28 -$2.59 -$3.56 -$5.66
Investing activities
Capital expenditures -$0 -$0.18 -$0.36 -$0.59
Investments
Total cash flows from investing -$0 -$0.18 -$0.36 -$0.59
Financing activities
Dividends paid
Sale and purchase of stock $1.05 -$0.52 $0.62 $0.01
Net borrowings -$0.17
Total cash flows from financing $0.89 $3.76 $4.28 $8.52
Effect of exchange rate $0.16 -$0.11 $0.04 $0.08
Change in cash and equivalents -$1.24 $0.88 $0.4 $2.35
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$20.63 -$28.63 -$16.16 -$16.83
Operating activities
Depreciation $2.8 $0.5 $0.4 $0.5
Business acquisitions & disposals
Stock-based compensation $1.23 $2.41 $1.83 $3.37
Total cash flows from operations -$14.09 -$26.76 -$16.71 -$12.79
Investing activities
Capital expenditures -$1.13 -$3.73 -$0.71 -$0.1
Investments
Total cash flows from investing -$1.13 -$3.73 -$0.71 -$0.1
Financing activities
Dividends paid
Sale and purchase of stock $9.67 $5.6 $29.98 $5.68
Net borrowings -$0.17 -$1 -$0.03 $2.31
Total cash flows from financing $17.43 $4.6 $29.95 $24.35
Effect of exchange rate $0.17 -$0.11 -$0.24 $0.32
Change in cash and equivalents $2.38 -$25.99 $12.3 $11.78
Fundamentals
Market cap $580.72K
Enterprise value $8.83M
Shares outstanding 3.42M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q -3.99%
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio 1.90
Book/Share 0.09
Cash/Share 1.92
EPS N/A
ROA N/A
ROE N/A
Debt/Equity -134.19
Net debt/EBITDA N/A
Current ratio 1.26
Quick ratio 0.68